LEADER 04308nam 2201465z- 450 001 9910566473703321 005 20220506 035 $a(CKB)5680000000037643 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81202 035 $a(oapen)doab81202 035 $a(EXLCZ)995680000000037643 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aMolecular Pathways in Cancers 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (284 p.) 311 08$a3-0365-3682-5 311 08$a3-0365-3681-7 330 $aThis book includes some recent works providing the readers with novel relevant findings about the main signaling pathways that govern the molecular pathogenesis of some of the highest prevalent human tumors, which are the basis for developing alternative therapeutic strategies to improve patient outcomes. 606 $aMedicine and Nursing$2bicssc 606 $aOncology$2bicssc 610 $aacetylation 610 $aactin cytoskeletal reorganization 610 $aadaptive immunity 610 $aadvanced ovarian cancer 610 $aanti-receptor therapy 610 $aBET inhibitors 610 $abiomarkers 610 $abladder cancer initiation 610 $abreast cancer 610 $aCALR 610 $acancer 610 $acancer immunology 610 $acancer therapeutics 610 $acarcinogenicity 610 $aCD99 agonist 610 $acomplement system 610 $aDUSP1 610 $aEGFR dimerization 610 $aendocytosis 610 $aepigenetic 610 $aepigenome 610 $aepithelial cells 610 $aFAK dephosphorylation 610 $agenome 610 $aglioblastoma 610 $agp120 610 $ahepatocellular carcinoma 610 $ahuman immunodeficiency virus type 1 610 $aimmune checkpoint inhibitors 610 $aimmune evasion 610 $aimmunotherapy 610 $ainnate immunity 610 $aJAK2 610 $aluminal breast cancer 610 $aMAPK 610 $amatrix protein p17 610 $ametastasis 610 $ametastatic melanoma 610 $amethylation 610 $amigration and invasion 610 $amitochondria 610 $amolecular targeted agents 610 $aMPL 610 $aMS-determined phosphopeptides 610 $amTOR 610 $amyeloproliferative neoplasms 610 $an/a 610 $aNef 610 $aNIMA-related kinase 1 (NEK1) 610 $anon-coding RNA 610 $aOMD 610 $aoncogenic signaling pathway 610 $aovarian cancer 610 $aoxidative stress 610 $aOXPHOS 610 $apancreatic ductal adenocarcinoma 610 $apartial EMT 610 $apatient survival 610 $apBRD4 610 $aPI3K 610 $aPP2A 610 $aPRELP 610 $aprognosis 610 $aprostate cancer 610 $aPTPN12 610 $aRac1 610 $areactive oxygen species 610 $aresistance 610 $areverse transcriptase 610 $aRhoA 610 $aSET 610 $asignaling pathways 610 $asmall-cell lung cancer 610 $aSnail 610 $asplicing pathway 610 $aTAK-228 610 $aTat 610 $athioridazine (THD) 610 $atight junction 610 $atousled-like kinase (TLK) 610 $aTPOR 610 $atrastuzumab 610 $atripeptide 610 $atriple negative breast cancer 610 $atriple-negative breast cancer 610 $atumor immune microenvironment 610 $atumor microenvironment 610 $atumor suppression gene 610 $aWarburg effect 610 $ayes-associated protein 1 (YAP1) 615 7$aMedicine and Nursing 615 7$aOncology 700 $aCristo?bal$b Ion$4edt$01309570 702 $aRodri?guez$b Marta$4edt 702 $aCristo?bal$b Ion$4oth 702 $aRodri?guez$b Marta$4oth 906 $aBOOK 912 $a9910566473703321 996 $aMolecular Pathways in Cancers$93029401 997 $aUNINA